Intermittent MEK Inhibition with GITR Costimulation Rescues T-cell Function for Increased Efficacy with CTLA-4 Blockade in Solid Tumor Models

Lauren Dong(Cornell University), Taha Merghoub(Weill Cornell Medicine)
Cancer Immunology Research
June 17, 2024
10.1158/2326-6066.cir-23-0729
Cited by 7

Related Papers

CTLA-4 blockade drives loss of Treg stability in glycolysis-low tumours
|Nature|2021|389
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
|Cell|2023|290
Pharmacologic LDH inhibition redirects intratumoral glucose uptake and improves antitumor immunity in solid tumor models
|Journal of Clinical Investigation|2024|65
APR-246 increases tumor antigenicity independent of p53
|Life Science Alliance|2023|5